Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial (Q38385068)

2 September 2017

title

Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial (English)

1 reference

2 September 2017

1 reference

William R Shanahan

1

1 reference

2 September 2017

Jed E Rose

2

1 reference

2 September 2017

Alan Glicklich

3

1 reference

2 September 2017

Scott Stubbe

4

1 reference

2 September 2017

Matilde Sanchez-Kam

5

1 reference

2 September 2017

language of work or name

1 reference

4 November 2016

1 reference

Nicotine and Tobacco Research

2 September 2017

published in

1 reference

Current and emerging pharmacotherapeutic options for smoking cessation.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Pharmacological interventions for smoking cessation: an overview and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The hardening hypothesis: Is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Predictors of quit attempts and abstinence among smokers not currently interested in quitting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Effectiveness of varenicline for smoking cessation at 2 urban academic health centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Weight gain in smokers after quitting cigarettes: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Obesity: is weight gain after smoking cessation an important concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Motives for smoking and their correlates in clients attending Stop Smoking treatment services

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Lorcaserin, a 5-HT2C Agonist, Decreases Nicotine Self-Administration in Female Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTW301

21 January 2018

Identifiers

DOI

10.1093/NTR/NTW301

0 references

1 reference